More articles from Feature Article

You have access
Continuous Glucose Monitoring Use in Clinical Trials for On-Market Diabetes Drugs
Bradley Q. Fox, Peninah F. Benjamin, Ammara Aqeel, Emily Fitts, Spencer Flynn, Brian Levine, Elizaveta Maslak, Rebecca L. Milner, Benjamin Ose, Michael Poeschla, Meghna Ray, Maeve Serino, Sahaj S. Shah, Kelly L. Close

Clinical Diabetes Jan 2021, cd200049; DOI: 10.2337/cd20-0049
You have access
Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence
Timothy Reid

Clinical Diabetes Jan 2012, 30 (1) 3-12; DOI: 10.2337/diaclin.30.1.3
You have access
Effective Use of Structured Self-Management of Blood Glucose in Type 2 Diabetes: Lessons From the STeP Study
Christopher G. Parkin, Deborah A. Hinnen, David L. Tetrick

Clinical Diabetes Oct 2011, 29 (4) 131-138; DOI: 10.2337/diaclin.29.4.131

Main menu